FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: IBM to Add 750 AI, Quantum Computing Jobs in Chicago

By

-- International Business Machines (IBM) plans to add 750 jobs over the next five years focused at the Illinois Quantum and Microelectronics Park in Chicago, Bloomberg reported Wednesday, citing a joint statement by the company and Illinois Governor JB Pritzker.

The positions will be focused on artificial intelligence, quantum computing, cybersecurity and data science, the report said.

IBM, which will get $19 million from a sate tax-credit program, will also establish the FutureNow Chicago center at the hub, according to the report.

IBM didn't immediately reply to a request for comment from.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: $230.48, Change: $-2.57, Percent Change: -1.10%

Related Articles

Research

Update: Mizuho Keeps Price Target on Immix Biopharma to $15, Maintains Outperform Rating

(Updated to keep price target unchanged).(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $8.57, Change: $-0.04, Percent Change: -0.41%

$IMMX
Research

Update: Mizuho Keeps Price Target on IDEAYA Biosciences to $52, Maintains Outperform Rating

(Updated to keep price target unchanged).IDEAYA Biosciences (IDYA) has an average rating of buy and mean price target of $52.81, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $28.34, Change: $-0.73, Percent Change: -2.51%

$IDYA
Research

Update: Mizuho Securities Keeps Price Target on Apellis Pharmaceuticals to $41, Maintains Neutral Rating

(Updated to keep price target unchanged).Apellis Pharmaceuticals (APLS) has an average rating of hold and mean price target of $40.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.95, Change: $-0.05, Percent Change: -0.11%

$APLS